Texas InstrumentsREF3025AIDBZTVoltage References

V-Ref Fixed 2.5V 25mA 3-Pin SOT-23 T/R

Even in the event of large power supply variations, this REF3025AIDBZT voltage reference power management device from Texas Instruments can produce and maintain a precise DC voltage. It has an initial accuracy of 0.2%. With an output that has a voltage of 2.5 V, this is power management at its best. This will operate at a maximum voltage of 7 V, making it easy to control the power in your circuit. By operating at a load regulation of 100uV/mA and line regulation of 325uV/V you can provide a constant voltage at your output. This voltage reference circuit supports series topology. This product will be shipped in tape and reel packaging for quick mounting and safe delivery. This voltage reference circuit has an operating temperature range of -40 °C to 125 °C. It runs with a maximum temperature coefficient of 75ppm/°C.

Total In Stock: 5,025 parts

Regional Inventory: 25

    Total$1.27Price for 1

    25 In stock: Ships tomorrow

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2430+
      Manufacturer Lead Time:
      12 weeks
      Minimum Of :
      1
      Maximum Of:
      25
      Country Of origin:
      Thailand
         
      • Price: $1.2716
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2430+
      Manufacturer Lead Time:
      12 weeks
      Country Of origin:
      Thailand
      • In Stock: 25 parts
      • Price: $1.2716
    • (250)

      Ships in 3 days

      Ships from:
      Hong Kong
      Date Code:
      2440+
      Manufacturer Lead Time:
      12 weeks
      Country Of origin:
      Taiwan
      • In Stock: 5,000 parts
      • Price: $0.5953

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.